Creotech Instruments S.A.

WSE:CRI Stock Report

Market Cap: zł361.7m

Creotech Instruments Valuation

Is CRI undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CRI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate CRI's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate CRI's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CRI?

Key metric: As CRI is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for CRI. This is calculated by dividing CRI's market cap by their current revenue.
What is CRI's PS Ratio?
PS Ratio8.7x
Saleszł41.33m
Market Capzł361.66m

Price to Sales Ratio vs Peers

How does CRI's PS Ratio compare to its peers?

The above table shows the PS ratio for CRI vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.7x
LBW Lubawa
1.5xn/azł683.1m
MSZ Mostostal Zabrze
0.4x5.7%zł345.1m
MCR Mercor
0.7xn/azł423.4m
DEK Dekpol
0.2xn/azł392.2m
CRI Creotech Instruments
8.7xn/azł361.7m

Price-To-Sales vs Peers: CRI is expensive based on its Price-To-Sales Ratio (8.7x) compared to the peer average (0.7x).


Price to Sales Ratio vs Industry

How does CRI's PS Ratio compare vs other companies in the European Aerospace & Defense Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
CRI 8.7xIndustry Avg. 1.6xNo. of Companies10PS01.22.43.64.86+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: CRI is expensive based on its Price-To-Sales Ratio (8.7x) compared to the European Aerospace & Defense industry average (1.6x).


Price to Sales Ratio vs Fair Ratio

What is CRI's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CRI PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio8.7x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate CRI's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies